Document is current
Any future updates will be listed below
-
Authors
Legrand, Matthieu https://orcid.org/0000-0001-9788-5316
Clark, Audra T.
Neyra, Javier A.
Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
- License Information
-
More Information
Article History
Accepted: 1 September 2023
First Online: 27 September 2023
Competing interests
: M.O. has received Speaker honoraria from Fresenius Medical, Baxter and bioMérieux and research funding from Fresenius Medical, LaJolla Pharma and Baxter; these competing interests are not directly related to the topic of this Review. J.A.N. has received consulting fees from Baxter, Leadiant Biosciences and Outset. M.L. and A.T.C. report no competing interests.
